Order Article Reprints

Park GE, Ko J-H, Cho SY, Huh HJ, Baek JY, Ko KS, Kang C-I, Chung DR, Peck KR. Clinical Impact of Revised Ciprofloxacin Breakpoint in Patients with Urinary Tract Infections by Enterobacteriaceae. Antibiotics. 2021; 10(4):469. https://doi.org/10.3390/antibiotics10040469

Park, Ga Eun, Jae-Hoon Ko, Sun Young Cho, Hee Jae Huh, Jin Yang Baek, Kwan Soo Ko, Cheol-In Kang, Doo Ryeon Chung, and Kyong Ran Peck. 2021. "Clinical Impact of Revised Ciprofloxacin Breakpoint in Patients with Urinary Tract Infections by Enterobacteriaceae" Antibiotics 10, no. 4: 469. https://doi.org/10.3390/antibiotics10040469

Park, G. E., Ko, J.-H., Cho, S. Y., Huh, H. J., Baek, J. Y., Ko, K. S., Kang, C.-I., Chung, D. R., & Peck, K. R. (2021). Clinical Impact of Revised Ciprofloxacin Breakpoint in Patients with Urinary Tract Infections by Enterobacteriaceae. Antibiotics, 10(4), 469. https://doi.org/10.3390/antibiotics10040469